CDP571, a Humanized Anti-Tumor Necrosis Factor-α Monoclonal Antibody in Pediatric Crohn’s Disease
Petar Mamula(Children's Hospital of Philadelphia), Robert N. Baldassano(Children's Hospital of Philadelphia), Barbara S. Kirschner(Comer Children's Hospital), Stanley A. Cohen(Troy Gastroenterology), Harland S. Winter(Massachusetts General Hospital), Alison Innes(UCB Pharma (United Kingdom)), Jatin Patel(UCB Pharma (United Kingdom)), George D. Ferry(Baylor College of Medicine)
Cited by 20
Related Papers
Human gut microbiome viewed across age and geography
|Nature|2012|7.9k
Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
|Science|2011|6.6k
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
|Cell Host & Microbe|2014|3.3k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k